| NCT Number | NCT06569784 |
| Lead Sponsor | Xizang Haisco Pharmaceutical Co., Ltd |
| Conditions | Healthy |
| Enrollment | 6 participants |
| Start Date | 2024-05-30 |
| Primary Completion | 2024-07-02 (estimated) |
| Study Completion | 2024-10-30 (estimated) |
| Updated on ClinicalTrials.gov | 2024-08-26 |